Current Illinois CancerCare Clinical Trials

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Study Number: NRG-BR007

Study Summary:
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.

Status: Open

Radiation at OSF-Glen Oak, OSF-Rt 91, OSF Saint Joseph (Bloomington), UnityPoint-Methodist, and Western Illinois Cancer Treatment Center (Galesburg)

Study Coordinator(s)
  • Navigator Angie, 309-243-3613, aearles@illinoiscancercare.com
  • Michelle, 309-243-3622, mmartin@illinoiscancercare.com

Study Link

« Search Again